135 related articles for article (PubMed ID: 19863724)
1. Müeller-Hinton methylene blue media as an alternative to RPMI 1640 for determining the susceptibility of Cryptococcus neoformans and Cryptococcus gattii to posaconazole with Etest.
Alvarado-Ramírez E; Torres-Rodríguez JM; Murciano F; Sellart M
Mycoses; 2010 Mar; 53(2):114-6. PubMed ID: 19863724
[TBL] [Abstract][Full Text] [Related]
2. Comparison of three commercial assays and a modified disk diffusion assay with two broth microdilution reference assays for testing zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with posaconazole and amphotericin B.
Espinel-Ingroff A
J Clin Microbiol; 2006 Oct; 44(10):3616-22. PubMed ID: 16943356
[TBL] [Abstract][Full Text] [Related]
3. Correlation of Etest and Neo-Sensitabs diffusion assays on Mueller-Hinton-methylene blue agar with broth microdilution reference method (CLSI-M27-A2) for testing susceptibilities of Cryptococcus neoformans to amphotericin B and fluconazole.
Ochiuzzi ME; Santiso GM; Arechavala AI
Med Mycol; 2010 Sep; 48(6):893-6. PubMed ID: 20370370
[TBL] [Abstract][Full Text] [Related]
4. Cryptococcus neoformans serotype A and Cryptococcus gattii serotype B isolates differ in their susceptibilities to fluconazole and voriconazole.
Khan ZU; Randhawa HS; Chehadeh W; Chowdhary A; Kowshik T; Chandy R
Int J Antimicrob Agents; 2009 Jun; 33(6):559-63. PubMed ID: 19195846
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the etest method using Mueller-Hinton agar with glucose and methylene blue for determining amphotericin B MICs for 4,936 clinical isolates of Candida species.
Pfaller MA; Boyken L; Messer SA; Tendolkar S; Hollis RJ; Diekema DJ
J Clin Microbiol; 2004 Nov; 42(11):4977-9. PubMed ID: 15528683
[TBL] [Abstract][Full Text] [Related]
6. Influence of different susceptibility testing methods and media on determination of the relevant fluconazole minimum inhibitory concentrations for heavy trailing Candida isolates with low-high phenotype.
Alp S; Sancak B; Hascelik G; Arikan S
Mycoses; 2010 Nov; 53(6):475-80. PubMed ID: 19563491
[TBL] [Abstract][Full Text] [Related]
7. Determination of the minimum inhibitory concentration of Cryptococcus neoformans and Cryptococcus gattii against fluconazole by flow cytometry.
Morales BP; Junior IN; Trilles L; Bertho AL; Oliveira Rde V; Nishikawa MM; Elias Mdos S; Wanke B; Lazéra Mdos S
Med Mycol; 2014 Jan; 52(1):90-8. PubMed ID: 23808405
[TBL] [Abstract][Full Text] [Related]
8. [In vitro synergisms among hydrazones, ajoeno and posaconazole against Cryptococcus spp].
Vivas J; Alvarado P; Visbal G; Alvarez-Aular A; Ruiz E; Ledezma E
Invest Clin; 2011 Dec; 52(4):312-22. PubMed ID: 22523841
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Neo-Sensitabs diffusion method for determining the antifungal susceptibilities of Cryptococcus gattii isolates, using three different agar media.
Pujol I; Pastor FJ; dos Santos Lazéra M; Guarro J
Rev Iberoam Micol; 2008 Dec; 25(4):215-20. PubMed ID: 19071889
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Etest method for determining voriconazole and amphotericin B MICs for 162 clinical isolates of Cryptococcus neoformans.
Maxwell MJ; Messer SA; Hollis RJ; Diekema DJ; Pfaller MA
J Clin Microbiol; 2003 Jan; 41(1):97-9. PubMed ID: 12517832
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility testing of amphotericin B for Cryptococcus neoformans variety grubii AFLP1/VNI and Cryptococcus gattii AFLP6/VGII by CLSI and flow cytometry.
Morales BP; Trilles L; Bertho ÁL; Junior IN; de Oliveira Rde V; Wanke B; Lazéra Mdos S
Mycoses; 2015 May; 58(5):273-9. PubMed ID: 25756839
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Etest method for determining isavuconazole MICs against Cryptococcus gattii and Cryptococcus neoformans.
Thompson GR; Fothergill AW; Wiederhold NP; Vallor AC; Wickes BL; Patterson TF
Antimicrob Agents Chemother; 2008 Aug; 52(8):2959-61. PubMed ID: 18559645
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of Cryptococcus gattii clinical isolates.
Gomez-Lopez A; Zaragoza O; Dos Anjos Martins M; Melhem MC; Rodriguez-Tudela JL; Cuenca-Estrella M
Clin Microbiol Infect; 2008 Jul; 14(7):727-30. PubMed ID: 18558948
[TBL] [Abstract][Full Text] [Related]
14. Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole.
Lee SC; Lo HJ; Fung CP; Lee N; See LC
J Microbiol Immunol Infect; 2009 Apr; 42(2):148-53. PubMed ID: 19597647
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility profile of clinical and environmental isolates of Cryptococcus neoformans and Cryptococcus gattii in Uberaba, Minas Gerais, Brazil.
Andrade-Silva L; Ferreira-Paim K; Mora DJ; Da Silva PR; Andrade AA; Araujo NE; Pedrosa AL; Silva-Vergara ML
Med Mycol; 2013 Aug; 51(6):635-40. PubMed ID: 23343452
[TBL] [Abstract][Full Text] [Related]
16. Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for the Cryptococcus neoformans-Cryptococcus gattii species complex using the CLSI M27-A3 broth microdilution method.
Espinel-Ingroff A; Chowdhary A; Gonzalez GM; Guinea J; Hagen F; Meis JF; Thompson GR; Turnidge J
Antimicrob Agents Chemother; 2015 Jan; 59(1):666-8. PubMed ID: 25313209
[TBL] [Abstract][Full Text] [Related]
17. Correlation of antifungal susceptibility and molecular type within the Cryptococcus neoformans/C. gattii species complex.
Trilles L; Meyer W; Wanke B; Guarro J; Lazéra M
Med Mycol; 2012 Apr; 50(3):328-32. PubMed ID: 21859388
[TBL] [Abstract][Full Text] [Related]
18. Quality control limits for posaconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blue.
Brown S; Traczewski M
J Clin Microbiol; 2007 Jan; 45(1):222-3. PubMed ID: 17093031
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the NCCLS M44-P disk diffusion method for determining susceptibilities of 276 clinical isolates of Cryptococcus neoformans to fluconazole.
Pfaller MA; Messer SA; Boyken L; Rice C; Tendolkar S; Hollis RJ; Diekema DJ
J Clin Microbiol; 2004 Jan; 42(1):380-3. PubMed ID: 14715784
[TBL] [Abstract][Full Text] [Related]
20. Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans.
Thompson GR; Wiederhold NP; Fothergill AW; Vallor AC; Wickes BL; Patterson TF
Antimicrob Agents Chemother; 2009 Jan; 53(1):309-11. PubMed ID: 18955539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
